{
    "nctId": "NCT06075953",
    "briefTitle": "DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment",
    "officialTitle": "DCIS: RECAST Trial -Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment: a Breast Cancer Prevention Pilot Study",
    "overallStatus": "RECRUITING",
    "conditions": "Ductal Carcinoma in Situ",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 400,
    "primaryOutcomeMeasure": "Patients remaining on active surveillance at 7 months",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female, at least 18 years old\n* previous diagnosis of Hormone Receptor positive (HR+) DCIS (at least 50% ER or PR and 2+; biopsy will have been performed previously at diagnosis) with or without microinvasion\n* Informed consent provided by the patient\n* Willingness and ability to provide tumor samples for research\n\nExclusion Criteria:\n\n* Pregnant or actively breastfeeding women (must be documented by a pregnancy test during screening)\n* History of allergic reactions attributed to compounds of similar chemical or biologic composition to study agent based on review of the medical record and patient history.\n* Invasive carcinoma or identification of a mass on MRI that is subsequently biopsied and found to be invasive cancer\n* Co-enrollment in clinical trials of pharmacologic agents requiring an Investigational new Drug Appilcation (IND)\n* Ongoing treatment for DCIS other than what is specified in this protocol\n* Uncontrolled intercurrent illness, including psychiatric conditions, that would limit compliance with study requirements.\n* Medical history or ongoing gastrointestinal disorders potentially affecting the absorption of investigational agent and/or tamoxifen. Participants unable to swallow normally or unable to take tablets and capsules. Predictable poor compliance to oral treatment. Active inflammatory bowel disease or chronic diarrhea, known active hepatitis A/B/C\\*, hepatic cirrhosis, short bowel syndrome, or any upper gastrointestinal surgery including gastric resection or banding procedures.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}